CCAP
Crescent Capital BDC, Inc.
Financial Services — Asset Management
Crescent Capital BDC, Inc. is as a business development company is a private debt fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
None
7 analysts
$9.17
$-0.01 (-0.11%)
Target:
$14.00
(52.7%)
Price History
52-Week Range
Sign in to add CCAP to a watchlist or set price alerts.
Fundamentals
| Market Cap | $408.99M |
| P/E Ratio (TTM) | 27.75 |
| Forward P/E | 7.44 |
| EPS (TTM) | $0.40 |
| Dividend Yield | 14.41% |
| Profit Margin | 9.25% |
| Revenue Growth | -10.00% |
| ROE | 2.15% |
| Debt/Equity | 134.82 |
| Recommendation | None |
| Analyst Target | $14.00 |
| Analysts | 7 |
| Next Earnings | Aug 10, 2026 AMC |
| Indexes | - |
Technical Indicators
| RSI (14) | 44.4 |
| Beta | 0.58 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $16.04 |
| 52-Week Low | $10.77 |
| 50-Day Avg | $12.03 |
| 200-Day Avg | $13.48 |
| Avg Volume | 236.4K |
| Volume | 303.8K |
Performance Analysis
NEUTRALCCAP presents a mixed picture with both positive and negative indicators.
+
Trading near its 52-week low ($10.77), which could present a value opportunity.
~
RSI at 44.4 is in neutral territory.
-
Price is below both the 50-day and 200-day moving averages — in a downtrend.
-
Revenue declined 10.0% year-over-year.
~
Wall Street consensus is "none" from 7 analysts.
+
Average analyst target of $14.00 implies 52.7% upside.
Recent News
Loading news...
Last updated: Jul 02, 2026 13:02 UTC
Back to Screener Export Report